First, both BRCA1 and BRCA2 are tumour suppressor genes and most often involve wild-type loss of heterozygosity (wt-LOH) in mutation carriers' tumours [20,21], resulting in both parental copies of the gene being damaged in line with Knudson's two-hit model [22]. The gene discussed is BRCA2; the disease is neoplasm.